Skip to content

A clinical trial to compare tissue reaction/inflammation with Trusilk�® (Healthium) and Mersilk�® (Johnson & Johnson) silk sutures post primary closure of mucosa in subjects undergoing planned surgical removal of impacted mandibular third molar at 72 hours and 7 days.

Single blind, randomized study comparing clinical equivalence of Trusilk�® (Healthium) and Mersilk�® (Johnson & Johnson) silk suture, for primary closure of mucosa in subjects undergoing planned surgical removal of mesioangular impacted mandibular third molar

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024100
Enrollment
132
Registered
2020-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Trusilk: Trusilk natural non-absorbable black braided silk suture of size 3-0 will be used to close the oral mucosal incisions. The suture material will be removed after 7-14 days depen

Sponsors

Healthium Medtech PvtLtd formerly Sutures India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects, both male and female, aged 20-40 years 2. Subjects having mesioangular impacted mandibular 3rd molar 3. Subjects requiring mucosal suturing 4. Subjects who have given informed consent 5. Subjects classified under ASA I and II

Exclusion criteria

Exclusion criteria: 1. Subjects having infected molar teeth or complicated impacted 3rd molar 2. Pregnant or lactating women 3. Subjects with history of allergy to silk or similar products 4. Subjects on drugs like aspirin, blood thinners and anticoagulant therapy 5. Subjects receiving any type of local and systemic drugs which can produce inflammation in gingival tissue 6. Subjects with history of systemic diseases such as diabetes mellitus, tuberculosis, bleeding disorders, osteoporosis, unstable or life-threatening conditions, those undergoing radiation therapies. 7. Subjects those who had the habit of drug abuse 8. Subjects already participating in another trial 9. Subjects who received an experimental drug or used an experimental medical device within 30 days prior to the planned start of procedure 10. Subjects unlikely to comply with surgical procedure or complete the scheduled follow up visit, in the opinion of investigator 11. Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center 12. Other indication or the reason for exclusion, in the opinion of investigator

Design outcomes

Primary

MeasureTime frame
To compare tissue reaction/inflammation with Trusilk�® (Healthium) and Mersilk�® (Johnson & Johnson) silk sutures post primary closure of mucosa in subjects undergoing planned surgical removal of impacted mandibular third molar at 72 hours and 7 daysTimepoint: 72 hours and 7 days

Secondary

MeasureTime frame
1. To assess the incidence of tissue reaction and infection between the two groups 2. To assess the effect of suture material on wound healing and other surgical outcomes 3. To assess overall intraoperative handling between the two sutures 4. To compare the common post-surgical complications between two sutures 5. To compare bacterial accumulation on both suture materials (Exploratory outcome)Timepoint: Day 3 Day 7 Day 12 Day 30 Month 3

Countries

India

Contacts

Public ContactDr Ashok Moharana

Healthium Medtech Pvt.Ltd. (formerly Sutures India Pvt. Ltd.)

ashok.m@healthiummedtech.com9717887751

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 17, 2026